CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 54 filers reported holding CABALETTA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,148,851 | +552.8% | 141,186 | +453.7% | 0.00% | – |
| Q2 2023 | $329,179 | +349.7% | 25,498 | +188.1% | 0.00% | – |
| Q1 2023 | $73,197 | +546.0% | 8,851 | +622.5% | 0.00% | – |
| Q4 2022 | $11,331 | +88.8% | 1,225 | -86.7% | 0.00% | – |
| Q3 2022 | $6,000 | -62.5% | 9,194 | -39.7% | 0.00% | – |
| Q2 2022 | $16,000 | -75.8% | 15,247 | -52.9% | 0.00% | – |
| Q1 2022 | $66,000 | +144.4% | 32,379 | +355.3% | 0.00% | – |
| Q4 2021 | $27,000 | -84.7% | 7,111 | -51.0% | 0.00% | – |
| Q3 2021 | $176,000 | +1.1% | 14,507 | -28.2% | 0.00% | – |
| Q2 2021 | $174,000 | +56.8% | 20,205 | +102.5% | 0.00% | – |
| Q1 2021 | $111,000 | +177.5% | 9,978 | +214.8% | 0.00% | – |
| Q4 2020 | $40,000 | -9.1% | 3,170 | -22.0% | 0.00% | – |
| Q3 2020 | $44,000 | -41.3% | 4,065 | -39.0% | 0.00% | – |
| Q2 2020 | $75,000 | +200.0% | 6,659 | +99.3% | 0.00% | – |
| Q1 2020 | $25,000 | +56.2% | 3,342 | +194.4% | 0.00% | – |
| Q4 2019 | $16,000 | – | 1,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
| Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
| Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
| Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
| Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
| HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
| Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
| SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
| Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |